OPTISURE
Device
Abbott Laboratories
Total Payments
$130,689
Transactions
362
Doctors
173
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,268 | 39 | 31 |
| 2023 | $48,505 | 77 | 47 |
| 2022 | $80,916 | 246 | 127 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $101,514 | 10 | 77.7% |
| Debt forgiveness | $21,100 | 1 | 16.1% |
| Food and Beverage | $8,075 | 351 | 6.2% |
Payments by Type
Research
$101,514
10 transactions
General
$29,175
352 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Human Use Condition Study-Fluoroscopic Evaluation of 3D Curvature of Implanted Right Ventricular Leads in Humans | Abbott Laboratories | $100,014 | 0 |
| Optisure Lead Post Approval Study | Abbott Laboratories | $1,500 | 0 |
Top Doctors Receiving Payments for OPTISURE — Page 7
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Clinical Cardiac Electrophysiology | New Braunfels, TX | $10.54 | 1 |
| , MD | Clinical Cardiac Electrophysiology | Fort Lauderdale, FL | $10.52 | 1 |
| , M.D | Cardiovascular Disease | Houston, TX | $10.47 | 1 |
| , MD | Cardiovascular Disease | Philadelphia, PA | $9.66 | 2 |
| , M.D | Cardiovascular Disease | Brooklyn, NY | $8.77 | 1 |
| , MD | Cardiovascular Disease | Bryn Mawr, PA | $8.73 | 1 |
| , M.D | Internal Medicine | Phoenix, AZ | $8.27 | 1 |
| , M.D | Clinical Cardiac Electrophysiology | Bedford, TX | $7.87 | 1 |
| , D.O | Internal Medicine | Houston, TX | $6.86 | 2 |
| , M.D | Internal Medicine | New York, NY | $6.80 | 1 |
| , M.D | Cardiovascular Disease | New York, NY | $6.80 | 1 |
| , MD | Clinical Cardiac Electrophysiology | Fort Lauderdale, FL | $6.06 | 2 |
| , MD | Clinical Cardiac Electrophysiology | Weston, FL | $5.56 | 1 |
| , MD | Cardiovascular Disease | Gahanna, OH | $5.40 | 1 |
| , MD | Clinical Cardiac Electrophysiology | Cherry Hill, NJ | $4.71 | 1 |
| , M.B.B.S | Student in an Organized Health Care Education/Training Program | Winston Salem, NC | $4.50 | 1 |
| , MD | Cardiovascular Disease | San Francisco, CA | $4.49 | 1 |
| , MD | Internal Medicine | Ventura, CA | $4.48 | 1 |
| , MD | Cardiovascular Disease | Houston, TX | $4.45 | 1 |
| , MD | Pediatrics | Little Rock, AR | $4.15 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Houston, TX | $4.15 | 1 |
| , M.D | Clinical Cardiac Electrophysiology | Houston, TX | $3.52 | 1 |
| , M.D | Clinical Cardiac Electrophysiology | Houston, TX | $2.85 | 1 |
| , M.D | Interventional Cardiology | Lauderdale Lakes, FL | $1.65 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $130,689
Product Information
- Type Device
- Total Payments $130,689
- Total Doctors 173
- Transactions 362
About OPTISURE
OPTISURE is a device associated with $130,689 in payments to 173 healthcare providers, recorded across 362 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $1,268 was paid across 39 transactions to 31 doctors.
The most common payment nature for OPTISURE is "Unspecified" ($101,514, 77.7% of total).
OPTISURE is associated with 2 research studies, including "Human Use Condition Study-Fluoroscopic Evaluation of 3D Curvature of Implanted Right Ventricular Leads in Humans" ($100,014).